Journal List > J Korean Med Sci > v.30(12) > 1022830

TOOLS
Bae: Thyroid Cancer: We Need a Carcinogen-specific Genome Study
Opinion
Oncology & Hematology

Journal of Korean Medical Science 2015; 30(12): 1920-1921.

Published online: 30 November 2015

DOI: https://doi.org/10.3346/jkms.2015.30.12.1920

Thyroid Cancer: We Need a Carcinogen-specific Genome Study

Jong-Myon Bae

Department of Preventive Medicine, Jeju National University School of Medicine, Jeju, Korea.

Address for Correspondence: Jong-Myon Bae, MD. Department of Preventive Medicine, Jeju National University School of Medicine, 102 Jejudaehak-ro, Jeju 63241, Korea. Tel: +82.64-755-5567, Fax: +82.64-725-2593, jmbae@jejunu.ac.kr

© 2015 The Korean Academy of Medical Sciences.

(open-access):

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Thyroid cancer is the most common cancer among Koreans with 22.3% annual percentage change in incidence rates between the years of 1999 and 2012 (1). An age-period-cohort analysis showed a strong period effect (2), which supports the hypothesis that the dramatic increase in the incidence rates of thyroid cancer in Koreans is ascribable to over diagnosis due to the spread of diagnostic ultrasound (34). The results of a cohort study with residents living near nuclear power plants (NPPs) conducted by Ahn et al. (5), according to which only female thyroid cancer showed significantly higher incidence, can also be explained to be attributable to such over-diagnosis.
Nevertheless, some (678) demand an extended cohort study, putting forward a claim that this result should be interpreted in relation to the radiation exposure of NPP residents (9). However, it is doubtful that we need to extend the follow-up duration and reanalyze the collected data because of the following reasons. First, radiation levels near NPPs are not higher than other regions, as demonstrated by radiation monitoring (5). At such a low radiation level, additional follow-ups are completely meaningless. Second, adults exposed to acute radiation are not affected in relation to thyroid cancer, as demonstrated by the Chernobyl disaster (1011). Given this fact, there is no persuasive evidence to conduct follow-ups with adults living near NPPs that have no history of nuclear accidents. Third, previous cohort studies with residents near NPPs reported that low-dose radiation is not associated with the occurrence of thyroid cancer (1213).
On the other hand, a genuine research necessity lies in finding out whether the incidences of thyroid cancer among NPP residents are attributable to their radiation exposure or not. To put it another way, a radiation-specific genome study should be conducted. If the pathogenic mechanism of thyroid cancer in relation to radiation-induced problems at the genome level can be known, the findings can be efficiently applied to the determination of the radiation-related conditions specific to the thyroid cancer cases among NPP residents.
Through the results of previous studies conducted with Hiroshima atomic bombing victims and Chernobyl NPP accident victims, it is now known that while the thyroid cancer among highly sensitive pediatric patients is induced by RET/PTC rearrangements, BRAFV600E point mutation is responsible for the thyroid cancer developed in adulthood (141516). Given these facts, a more urgent research task would be to determine the incidence rates of thyroid cancer in the age group of ≤ 18 yr and perform a genome study on thyroid tumors in order to verify the influence of the radiation exposure of NPP residents.
Additionally, the Phenopedia of HuGE Navigator (17) lists a total of 359 genes associated with thyroid cancer as of July 2015. It would be useful to investigate the difference in genome distribution in the incidences of thyroid cancer between adult residents near NPPs and regions unaffected by the presence of NPPs in a case-control study.

Notes

DISCLOSURE The author have no potential conflicts of interest to disclose.

References

1. Jung KW, Won YJ, Kong HJ, Oh CM, Cho H, Lee DH, Lee KH. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat. 2015; 47:127–141.
2. Oh CM, Jung KW, Won YJ, Shin A, Kong HJ, Lee JS. Age-period-cohort analysis of thyroid cancer incidence in Korea. Cancer Res Treat. 2015; 47:362–369.
3. Ahn HS, Kim HJ, Welch HG. Korea's thyroid-cancer "epidemic"--screening and overdiagnosis. N Engl J Med. 2014; 371:1765–1767.
4. Kim CS. Thyroid cancer and radiation. J Korean Thyroid Assoc. 2015; 8:1–7.
5. Ahn YO, Li ZM. KREEC Study Group. Cancer risk in adult residents near nuclear power plants in Korea - a cohort study of 1992-2010. J Korean Med Sci. 2012; 27:999–1008.
6. Kim JM, Kim MH, Ju YS, Hwang SS, Ha M, Paek D. Re: cancer risk in adult residents near nuclear power plants in Korea: a cohort study of 1992-2010. J Korean Med Sci. 2014; 29:1436–1437.
7. Kim JM, Kim MH, Ju YS, Hwang SS, Ha M, Paek D. Rebuttal to authors' reply, re: cancer risk in adult residents near nuclear power plants in Korea: a cohort study of 1992-2010. J Korean Med Sci. 2015; 30:115–116.
8. Lee WJ. Cancer risk among population near nuclear power plants in Korea. J Korean Med Sci. 2015; 30:666–667.
9. Bae JM. A case report about doubting a misconduction of publication by a third party based on the confusing ownership of databases. J Med Life Sci. 2014; 11:77–81.
10. Reiners C. Radioactivity and thyroid cancer. Hormones (Athens). 2009; 8:185–191.
11. Moysich KB, Menezes RJ, Michalek AM. Chernobyl-related ionising radiation exposure and cancer risk: an epidemiological review. Lancet Oncol. 2002; 3:269–279.
12. Davis S, Kopecky KJ, Hamilton TE, Onstad L. Hanford Thyroid Disease Study Team. Thyroid neoplasia, autoimmune thyroiditis, and hypothyroidism in persons exposed to iodine 131 from the hanford nuclear site. JAMA. 2004; 292:2600–2613.
13. Bollaerts K, Fierens S, Van Bladel L, Simons K, Sonck M, Poffijn A, Geraets D, Gosselin P, Van Oyen H, Francart J, et al. Thyroid cancer incidence in the vicinity of nuclear sites in Belgium, 2000-2008. Thyroid. 2014; 24:906–917.
14. Dinets A, Hulchiy M, Sofiadis A, Ghaderi M, Höög A, Larsson C, Zedenius J. Clinical, genetic, and immunohistochemical characterization of 70 Ukrainian adult cases with post-Chornobyl papillary thyroid carcinoma. Eur J Endocrinol. 2012; 166:1049–1060.
15. Leeman-Neill RJ, Brenner AV, Little MP, Bogdanova TI, Hatch M, Zurnadzy LY, Mabuchi K, Tronko MD, Nikiforov YE. RET/PTC and PAX8/PPARγ chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics. Cancer. 2013; 119:1792–1799.
16. Tronko M, Bogdanova T, Voskoboynyk L, Zurnadzhy L, Shpak V, Gulak L. Radiation induced thyroid cancer: fundamental and applied aspects. Exp Oncol. 2010; 32:200–204.
17. HuGE Navigator. Phenopedia. accessed on 18 July 2015. Available at http://hugenavigator.net/HuGENavigator/startPagePhenoPedia.do.
TOOLS
ORCID iDs

Jong-Myon Bae
https://orcid.org/http://orcid.org/0000-0003-3080-7852

Similar articles